AIM ImmunoTech Inc (AIM)

[Milo2]

This part (see below) of the PR should be better emphasized by our CEO. Yes, in the TV interview, he rightly also draws attention to the long-term prospects of Ampligen with cancer therapeutics. But I think he could better tout the short-term potential to save lives in those infected with COVID-19. This is also personal for me as a physician on the frontlines in US.

ChinaGoAbroad CEO Jesse T H Chang states: "Ampligen has the potential to be a groundbreaking life-saving protective therapy. This drug may be useful for doctors, nurses, healthcare professionals, first responders and people exposed to the virus. Without better protection, infected professionals in our medical teams may continue to become martyrs on the frontlines of the battle against this highly contagious virus.